Abstract
Purpose
To evaluate morphological alterations of meibomian glands (MGs) in the dry anophthalmic socket syndrome (DASS).
Methods
Fifteen unilateral anophthalmic patients wearing cryolite glass prosthetic eyes were enrolled. All patients with clinical blepharitis or other significant eyelid abnormalities were excluded. In vivo laser scanning confocal microscopy (LSCM) of the MGs in the lower eyelids both on the anophthalmic side and the healthy fellow eye was performed to quantify acinar unit density, acinar unit diameter, acinar unit area, meibum secretion reflectivity, the inhomogeneous appearance of the glandular interstice, and inhomogeneous appearance of the acinar walls.
Results
The lower eyelids of the anophthalmic sockets revealed a significant reduction of the acinar unit density (p = 0.003) as well as a significantly more inhomogeneous appearance of the periglandular interstices (p = 0.018) and the acinar unit walls (p = 0.015) than the healthy fellow eyelid. However, there were no significant differences regarding the acinar unit diameter, acinar unit area, and meibum secretion reflectivity of the MGs on the anophthalmic side compared to the healthy fellow eyelid (p ≥ 0.05, respectively).
Conclusions
The eyelids of anophthalmic sockets without clinical blepharitis demonstrate a reduced density of MG acinar units and a more inhomogeneous appearance of the periglandular interstices and the acinar unit walls. This can cause meibomian gland dysfunction contributing to DASS and suggests early treatment of these symptomatic patients, even in the clinical absence of any blepharitis signs.
Similar content being viewed by others
Introduction
A majority of the anophthalmic patients suffer from dry anophthalmic socket syndrome (DASS) resulting in significant socket discomfort [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35]. The degree of dry socket complaints ranges from trivial to severe and the reasons for DASS seem to be very variable, individual, and multifactorial [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35]. Previous studies have reported dry eye symptoms in anophthalmic sockets and have investigated the reasons for that condition [17,18,19,20,21,22,23,24,25,26, 29, 30, 33, 35]. These studies showed partially reduced tear production and reduced reflex tears in anophthalmic sockets, in particular in symptomatic patients [18, 24, 26, 27, 29]. Other reasons for dry eye symptoms in anophthalmic sockets seem to include loss of goblet cells, lid margin abnormalities, lagophthalmos, a reduced tear meniscus, conjunctivitis, and eyelid laxity [21, 22, 24, 25, 27, 29, 33]. As a result, DASS has been defined as a disease of the socket surface characterized by a loss of tear film homeostasis accompanied by socket discomfort, in which tear film instability, conjunctival inflammation, and damage, as well as eyelid and neurosensory abnormalities, play etiological roles [35]. In addition, while a higher incidence of clinical blepharitis in anophthalmic sockets was reported in two small series [22, 29], it is not fully understood why over 63% of anophthalmic patients have significantly more subjective dryness complaints on the anophthalmic side compared to the healthy fellow eye, even in absence of tear deficiency and clinical blepharitis [35].
The authors are not aware of any systematic, prospective study investigating and quantifying morphological changes of meibomian glands (MGs) in anophthalmic sockets without signs of clinical blepharitis until now. We are also unaware of any study comparing the morphology of MGs of anophthalmic sockets with the healthy fellow eye in these patients [35]. Furthermore, the exact roles and interactions of etiological causes of DASS are obscure [35] and there is a high priority to establish a standardized examination protocol and to develop an evidence-based treatment algorithm for DASS [35].
The purposes of the present study were to evaluate potential morphological changes of MGs in anophthalmic sockets without clinical blepharitis using in vivo confocal laser scanning microscopy to compare the morphology of the MGs with the heathy fellow eye, to evaluate dry anophthalmic socket symptoms in these patients, and to investigate factors associated with potential morphological changes of the MGs.
Subjects and methods
The study was approved by the Institutional Review Board of the University of Cologne and all performed procedures were in adherence to the tenets of the Declaration of Helsinki. Sixteen unilateral prosthetic eye patients of the Trester Institute, Cologne, Germany were approached over 11 consecutive days. Informed consent was obtained from all participants. Exclusion criteria included: not understanding the German language, younger than 18 years of age, less than 1 year wearing a prosthetic eye, a history of any ocular surface disease, known blepharitis or dysfunction of the MGs, surgical or laser interventions, contact lens wear, the use of topical medication, systemic diseases causing dry eye, chemotherapy, facial palsy, intravitreal operative injections, trigeminus or other facial nerve lesions, radiotherapy, eyelid injuries, socket or eyelid surgery in the last 3 months, and occlusion of the lacrimal system. Patients who used anti-inflammatory or antibiotic medication in either eye in the last half year were also excluded as were patients with defective or poor fitting prostheses.
Patients were asked face-to-face to complete a standardized dry eye questionnaire [36] modified for patients wearing prosthetic eyes. The first section asked demographic questions which included age, sex, ethnicity, date, the reason for eye loss, type of surgery, years of wearing a prosthesis, age of the present prosthesis, cleaning regime (>once daily, daily, between daily and weekly, weekly, between weekly and monthly, monthly, >monthly) and the presence of environmental factors causing dry eye. The second section focused on the history of their topical medication at any time point and external and systemic factors influencing dry eye symptoms. The third section included three established and standardized dry eye questionnaires [37,38,39,40]. Separately for the anophthalmic socket and the healthy fellow eye, German versions of the Ocular Surface Disease Index (OSDI), the 5-Item Dry Eye Questionnaire (DEQ-5), and the modified version of the Symptom Assessment iN Dry Eye (SANDE) questionnaire were completed. All vision-related questions were classified as not answered for the anophthalmic site.
A clinical examination was carried out to evaluate palpebral conjunctival inflammation using Pine et al.’s 0–4 grading scale [4, 5, 10] and the presence of eyelid abnormalities including ectropion, entropion, lagophthalmos, ptosis, as well as anterior and posterior blepharitis [35]. Schirmer I test (I-DEW Tearstrips, Mitron) following the application of one anesthetic eye drop (Oxybuprocaine 0.4%, Novesine®) was performed bilaterally [35]. The amount of wetting measured in millimeters was evaluated after 5 min [35]. Results under 5 mm were classified as pathological, 6–10 mm as borderline, and over 10 mm as normal [35].
Image acquisition
In vivo laser scanning confocal microscopy (LSCM) was performed bilaterally with the Heidelberg Retina Tomograph III (Heidelberg Engineering GmbH, Dossenheim, Germany) using a diode laser with a wavelength of 670 nm. The HRT was equipped with the Rostock Cornea Module (RCM, 63x water-immersion objective lens, Carl Zeiss Meditec, Inc., Dublin, CA) enabling a scanning area of 400 × 400 µm with a resolution of 380 × 380 pixels. The RCM was covered with a sterile polymethacrylate cap (Tomo-Cap; Heidelberg Engineering). Before every examination session, one drop of Oxybuprocaine 0,4% (Novesine®) was instilled bilaterally. After the patients‘ head was placed in the headrest with the eyes looking at a fixed point slightly upwards, the lower eyelid was everted, and the centre of the Tomo-Cap was horizontally positioned on the centre of the lower eyelid margin. The focus was adjusted manually while the section mode imaging modality was used. Images of the meibomian acinar units were taken manually while the focus was continuously adjusted into deeper layers of tissue.
Image analysis
For each patient, three high-quality images of various depths of the lower eyelid tissue were chosen randomly for the healthy fellow eye and the anophthalmic socket. ImageJ (open-source software program, National Institutes of Health, USA) was used as the image processing tool. The density of the MG acinar units was identified by marking acinar units manually (Fig. 1) and mean values were calculated. Acinar unit diameters were measured along the longest axis of the acinar units and acinar unit areas were measured along the inner acinar unit walls. Minimum, maximum, as well as mean values, were recorded. Secretion reflectivity and inhomogeneous appearance of acinar unit walls and the inhomogeneous appearance of the periglandular interstices were graded based on a 4-point scale developed by Villani et al. [41, 42].
Statistical analyses
SPSS Version 26.0 for Mac (SPSS, Inc., Chicago, IL) was used for all statistical analyses. Shapiro–Wilk tests were performed to analyze the normal distribution of all scores, values, and measures of the LSCM. To compare the scores and values between the anophthalmic and fellow sides for the Schirmer test, the acinar unit diameters, acinar unit density, as well as mean and maximum acinar unit areas t-tests for paired samples due to normal distribution were performed, respectively. Wilcoxon tests were used to identify statistical differences for the scores of the three dry eye questionnaires, secretion reflectivity, inhomogeneous appearances of the interstices, and the acinar unit walls as well as the minimum acinar unit areas between the anophthalmic and fellow sides.
To compare the OSDI, SANDE, DEQ-5, conjunctival socket inflammation scores, and LSCM measures between enucleated, eviscerated, and not operated anophthalmic sockets Kruskal–Wallis tests and Mann–Whitney U tests as post hoc tests were performed, respectively.
To investigate factors related to LSCM values including acinar unit diameters, acinar unit areas, secretion reflectivity, and inhomogeneous appearance of acinar unit walls as well as the inhomogeneous appearance of the periglandular interstices general linear models were used (one for each LSCM measure) with explanatory variables. of age, gender (male vs. female), years of wearing a prosthesis, age of the current prosthesis, frequency cleaned (less than monthly, between weekly and monthly, less frequently than daily but up to and including weekly, exactly once daily, and more than once a day), the presence of environmental factors causing dry eye, as well as eyelid positions including ectropion, entropion, and lagophthalmos.
To investigate factors associated with OSDI, SANDE, DEQ-5 scores, Schirmer I test, and conjunctival socket inflammation grade general linear models were used, respectively, with explanatory variables. including acinar unit diameters, acinar unit areas, secretion reflectivity, and inhomogeneous appearance of acinar unit walls as well as the inhomogeneous appearance of the periglandular interstices.
The threshold for statistical significance was set at p < 0.05.
Results
Demographics of study population
Fifteen patients agreed to participate in the study with one patient declining due to the lack of time. Of these 15 patients, 11 were males and 4 were females. These 15 enrolled patients had a mean age of 46.2 ± 12. 7 years (range, 22–71 years) (Table 1). The right eye was lost in six cases (40%), the left eye in nine cases (60%). Reasons for eye loss included congenital (7%), medical (13%), and accident (80%). Sixty percent (60%) of patients’ eyes were enucleated, 33% eviscerated, and 7% had a microphthalmos. The mean time since the present prosthesis was fitted was 1.4 ± 0.8 years (range, 1–4 years), and the mean time since eye loss was 27.2 ± 14.9 years (range, 1–64 years).
Eyelid positions and lagophthalmos
Of the 15 anophthalmic patients, one (6.7%) had an ectropion, two (13.3%) had ptosis, and two (13.3%) had a lagophthalmos on the anophthalmic side (Table 2). There were no eyelid abnormalities on the healthy fellow sides.
Care and cleaning regimes
Four patients (26.7%) left their prosthesis out overnight. Ten patients (67%) washed their hands (before touching their prostheses) always, two patients (13%) mostly, and three patients (20%) sometimes or rarely. Eleven patients (73.3%) cleaned their prosthesis at least once a day, three patients (20%) less frequently than daily but up to weekly, and one patient (6.7%) never. Thirteen patients (86.7%) cleaned the prosthesis only with water, one (6.7%) with a disinfectant solution.
Topical medication
None of the patients used topical medication at the anophthalmic socket or healthy fellow eye.
Environmental factors relevant for dry eye symptoms and socket inflammation
Eight patients (53.3%) were exposed to at least one environmental factor in their daily life that might cause dry eye symptoms and two (13.3%) were exposed to two environmental factors. The environmental factors were: smoke (20%), dry air and draughts (13.3%), dust (20%), and air conditioners (13.3%).
Dry eye symptoms, socket inflammation, and Schirmer I test in anophthalmic sockets compared to the fellow eye
Patients had significantly higher scores in all dry eye questionnaires and significantly higher conjunctival inflammation on the anophthalmic site compared to the healthy fellow eye (p < 0.05) (Table 2). In addition, the study participants had significantly higher Schirmer I test values on the anophthalmic side compared to the healthy fellow eye (p = 0.017). However, the mean values were in a normal range bilaterally. There were no significant differences for socket inflammation, Schirmer I test with topical anesthesia, or for dry eye symptoms between enucleated, eviscerated, and non-operated patients (p > 0.05, respectively). Nine patients (60%) reported mild or more severe dry anophthalmic socket complaints in at least one of the three questionnaires.
In vivo LSCM of the MGs of the anophthalmic socket compared to the fellow eye
There were no significant differences for the acinar unit diameters, acinar unit areas, and meibum secretion reflectivity for the anophthalmic socket side compared to the fellow side (Figs. 1, 2, and 3). However, there was a significant difference in the acinar unit density (Table 3) with a lower density in the lower eyelid of the anophthalmic socket (Fig. 4). In addition, there were significant differences regarding the acinar units with a more inhomogeneous appearance of the acinar unit walls and the interstice on the anophthalmic side (Fig. 5).
Factors associated with LSCM measurements
All calculated general linear models were not significant (ANOVA: >0.05 for all models). None of the investigated factors, scores, or values was associated with LSCM measures including acinar unit diameters, acinar unit areas, secretion reflectivity, the inhomogeneous appearance of acinar unit walls, or the inhomogeneous appearance of the periglandular interstices.
Discussion
Nearly all of the study participants were very experienced and knowledgeable about wearing and handling prosthetic eyes and likely had deep insights into their problems with inflammation and especially with dry anophthalmic socket complaints. Despite the relatively small number of patients, the demographic data were very similar to the data of previous studies [3, 10, 11, 13, 35]. However, the small number is a limitation of this study as is the monocenter study design.
The higher scores of OSDI, SANDE, and DEQ-5 for the anophthalmic socket compared to the fellow eye and the finding that 60% of patients reported mild or more severe dry eye symptoms at least in one of the three questionnaires were in accordance with the results of previous studies [35]. However, since patients with clinical blepharitis were excluded from the study and previous studies have reported an association of blepharitis with higher MG dysfunction [21, 22, 29, 33, 35], the incidence of DASS is likely higher. Although 60% of all prosthetic eye wearers have at least mild dry socket symptoms, none of the study participants had a local therapy. The reasons for this remain unclear. It might be that these dry eye symptoms might be accepted by anophthalmic patients as normal in the same way that they accept mucoid discharge or perhaps there is a lack of awareness about DASS and/or of an evidence-based algorithm to treat it [1, 2, 10, 11, 13, 14, 23, 26, 35].
Our finding that patients in this study had significantly higher conjunctival inflammation on the anophthalmic side compared to the fellow eye also confirms the results of previous studies [10, 22, 35]. A longer wearing time of the current prosthesis (mean 1.4 years) over the recommended wearing time of 9 months and the frequent cleansings of the prostheses by most of the study participants can lead to higher mechanical irritation and socket inflammation [10, 22, 35]. These results suggest that prostheses should be updated on time and not be removed daily for cleaning, especially in the case of socket discomfort or socket inflammation [10, 35].
A reduced density of the MG acinar units and a more inhomogeneous appearance of the periglandular interstices and acinar unit walls in the LSCM of anophthalmic sockets without clinical signs of blepharitis might be a consequence of chronic socket inflammation. While there was no significant statistical association between the current grade of socket inflammation and morphological changes to the MGs this does not rule out the possibility that it is not the current grade of socket inflammation but rather that the duration of socket inflammation is the decisive factor. Chronic socket inflammation over long periods could lead to chronic inflammation of the periglandular interstice and of the acinar unit walls resulting in secondary loss of acinar units of the MGs, even in patients without any blepharitis signs.
That there were no significant differences for the acinar unit diameters, acinar unit areas, and meibum secretion reflectivity for the anophthalmic socket side compared with the fellow side may be a result of the exclusion of patients with any blepharitis, especially with blocked MG orifices which might have led to a changed consistency of the meibum resulting in a higher meibum secretion reflectivity in the LSCM as well as in higher acinar unit diameters and higher acinar unit areas.
Although patients had reduced acinar unit density of the MGs on the anophthalmic side and although most patients had significant dry anophthalmic socket complaints, Schirmer I tests were in a normal range bilaterally. Most previous studies have not shown a significant correlation between dry anophthalmic socket complaints and Schirmer test values [24, 26, 35, 43], suggesting that Schirmer tests may not provide sufficient diagnostic results in anophthalmic sockets [35]. The reason for this could be that there is not an absolute tear volume deficiency but rather a poor distribution of tears including a pooling in the lower fornices or behind the prosthesis [35]. The absence of a sufficient tear film over the anterior surface is likely to increase frictional resistance to blinking which in turn could add to socket inflammation. This indicates that treatment with artificial tears in these symptomatic anophthalmic patients is beneficial even in the absence of any clinical blepharitis signs.
Besides a validated and standardized questionnaire for dry anophthalmic socket complaints, ophthalmologists should evaluate patients using a standardized clinical examination protocol which includes a slit lamp examination especially with regard to conjunctival socket inflammation, anterior and posterior blepharitis, eyelid laxity, lagophthalmos, eyelid position, blink rate evaluation, and tear film break-up time. The fit and surface condition of the prosthesis should also be included while quantification of the tear meniscus and of goblet cells, evaluation of the bacterial flora, examination of the lacrimal drainage system, and MG imaging with LSCM, especially in symptomatic patients without signs of blepharitis would also be useful. The use of Schirmer tests in anophthalmic sockets is not evidence-based and further research should be undertaken in regard to this.
In summary, the majority of anophthalmic patients have significantly more dryness complaints on the anophthalmic side compared to the healthy fellow eye, even without absolute tear volume deficiency or clinical blepharitis. The DASS is a disease of the socket surface characterized by a loss of tear film homeostasis accompanied by socket discomfort, in which tear film instability, conjunctival inflammation, and damage, as well as eyelid and neurosensory abnormalities, play etiological roles [35]. Therefore, the diagnostic set of DASS should be updated to read: The presence of subjective symptoms in the anophthalmic socket are evaluated with standardized measurements (OSDI ≥ 13, SANDE ≥ 13, or DEQ-5 ≥ 6) and at least one of the five following clinical abnormalities: blepharitis anterior, blepharitis posterior, abnormalities of MGs in the in vivo confocal LSCM, reduced tear meniscus height, or conjunctival inflammation resulting in conjunctival staining. The establishment of a standardized examination protocol and treatment algorithm for DASS based on this updated diagnostic set should thus be a high priority. A standardized examination algorithm should include an evaluation of the MGs using LSCM in symptomatic patients even without signs of blepharitis or other eyelid abnormalities. Further research should be undertaken to investigate the role and the interactions of etiological causes for the DASS, especially with regard to the effect and interaction of anophthalmic socket inflammation and MG gland dysfunction.
Summary
What was known before
-
The dry anophthalmic socket syndrome (DASS) is a disease of the socket surface characterized by a loss of tear film homeostasis accompanied by socket discomfort, in which tear film instability, conjunctival inflammation, and damage, as well as eyelid and neurosensory abnormalities play etiological roles.
What this study adds
-
The eyelids of anophthalmic sockets without clinical blepharitis demonstrate a reduced density of meibomian gland acinar units and a more inhomogeneous appearance of the periglandular interstices and the acinar unit walls. This might cause meibomian gland dysfunction contributing to the DASS and suggests early treatment of these patients, even in the clinical absence of any blepharitis signs.
References
Pine K, Sloan B, Stewart J, Jacobs RJ. A survey of prosthetic eye wearers to investigate mucoid discharge. Clin Ophthalmol. 2012;6:707–13.
Pine KR, Sloan B, Jacobs RJ. Deposit buildup on prosthetic eyes and implications for conjunctival inflammation and mucoid discharge. Clin Ophthalmol. 2012;6:1755–62.
Pine KR, Sloan B, Jacobs RJ. Biosocial profile of New Zealand prosthetic eye wearers. N. Z Med J. 2012;125:29–38.
Pine KR, Sloan B, Jacobs RJ. The development of measurement tools for prosthetic eye research. Clin Exp Optom. 2013;96:32–8.
Pine KR, Sloan B, Stewart J, Jacobs RJ. The response of the anophthalmic socket to prosthetic eye wear. Clin Exp Optom. 2013;96:388–93.
Pine KR, Sloan BH, Jacobs RJ. A proposed model of the response of the anophthalmic socket to prosthetic eye wear and its application to the management of mucoid discharge. Med Hypotheses. 2013;81:300–5.
Pine NS, de Terte I, Pine KR. An investigation into discharge, visual perception, and appearance concerns of prosthetic eye wearers. Orbit. 2017;36:401–6.
Pine NS, De Terte I, Pine KR. The impact of eye loss and prosthetic eye wear on recreational, occupational and social areas of functioning. J Ophthalmol Vis Sci. 2017;2:1016.
Pine NS, De Terte I, Pine KR. Time heals: an investigation into how anophthalmic patients feel about eye loss and wearing a prosthetic eye. J Ophthalmol Vis Sci. 2017;2:1018.
Rokohl AC, Adler W, Koch KR, Mor JM, Jia R, Trester M, et al. Cryolite glass prosthetic eyes-the response of the anophthalmic socket. Graefes Arch Clin Exp Ophthalmol. 2019;257:2015–23.
Rokohl AC, Koch KR, Adler W, Trester M, Trester W, Pine NS, et al. Concerns of anophthalmic patients-a comparison between cryolite glass and polymethyl methacrylate prosthetic eye wearers. Graefes Arch Clin Exp Ophthalmol. 2018;256:1203–8.
Rokohl AC, Koch KR, Trester M, Heindl LM. Cryolite glass ocular prostheses and coralline hydroxyapatite implants for eye replacement following enucleation. Ophthalmologe. 2018;115:793–4.
Rokohl AC, Koch KR, Trester M, Trester W, Pine KR, Heindl LM. Concerns of anophthalmic patients wearing cryolite glass prosthetic eyes. Ophthalmic Plast Reconstr Surg. 2018;34:369–74.
Rokohl AC, Mor JM, Trester M, Koch KR, Heindl LM. Rehabilitation of Anophthalmic patients with prosthetic eyes in germany today - supply possibilities, daily use, complications and psychological aspects. Klin Monbl Augenheilkd. 2019;236:54–62.
Rokohl AC, Trester M, Pine KR, Heindl LM. Risk of breakage of cryolite glass prosthetic eyes. Graefes Arch Clin Exp Ophthalmol. 2019;257:437–8.
Litwin AS, Worrell E, Roos JC, Edwards B, Malhotra R. Can we improve the tolerance of an ocular prosthesis by enhancing its surface finish? Ophthalmic Plast Reconstruct Surg. 2018;34:130–5.
Bohman E, Roed Rassmusen ML, Kopp ED. Pain and discomfort in the anophthalmic socket. Curr Opin Ophthalmol. 2014;25:455–60.
Allen L, Kolder HE, Bulgarelli EM, Bulgarelli DM. Artificial eyes and tear measurements. Ophthalmology. 1980;87:155–7.
Fett DR, Scott R, Putterman AM. Evaluation of lubricants for the prosthetic eye wearer. Ophthal Plast Reconstr Surg. 1986;2:29–31.
Franca IS, Medrado J, Franca VP, Soares EJ. Treatment of dry anophthalmic cavities with labial salivary glands transplantation. Arq Bras Oftalmol. 2011;74:425–9.
Han JW, Yoon JS, Jang SY. Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study. Eye (Lond). 2014;28:1212–7.
Jang SY, Lee SY, Yoon JS. Meibomian gland dysfunction in longstanding prosthetic eye wearers. Br J Ophthalmol. 2013;97:398–402.
Jones CA, Collin JR. A classification and review the causes of discharging sockets. Trans Ophthalmol Soc UK. 1983;103:351–3.
Kim SE, Yoon JS, Lee SY. Tear measurement in prosthetic eye users with fourier-domain optical coherence tomography. Am J Ophthalmol. 2010;149:602–7 e601.
Ko JS, Seo Y, Chae MK, Jang SY, Yoon JS. Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers. Eye. 2018;32:439–45.
Adrian T, Lubis RR, Zubaidah TSH. Association between frequency of prosthesis cleaning and the discharge characteristics and the tear film in subjects with anophthalmic socket after eviceration with dermis fat graft. Open Access Maced J Med Sci. 2018;6:2012–6.
Vardizer Y, Lang Y, Mourits MP, Briscoe MD. Favorable effects of lacrimal plugs in patients with an anophthalmic socket. Orbit. 2007;26:263–6.
Schittkowski MP, Guthoff RF. Results of lacrimal assessment in patients with congenital clinical anophthalmos or blind microphthalmos. Br J Ophthalmol. 2007;91:1624–6.
Kashkouli MB, Zolfaghari R, Es’haghi A, Amirsardari A, Abtahi MB, Karimi N, et al. Tear film, lacrimal drainage system, and eyelid findings in subjects with anophthalmic socket discharge. Am J Ophthalmol. 2016;165:33–8.
Gupta R. OSC19: Customized liquid ocular prosthesis for anophthalmic patients suffering from dry eye: a clinical study. J Indian Prosthodont Soc. 2018;18:S15.
Rasmussen ML. Complications from eye prosthesis. Ugeskr Laege. 2008;170:2456–8.
Koch KR, Trester W, Muller-Uri N, Trester M, Cursiefen C, Heindl LM. Ocular prosthetics. Fitting, daily use and complications. Ophthalmologe. 2016;113:133–42.
Marcelo MTC, Ranche JM, Pe-Yan MR, Tuaño PMC, Trio-Ranche FK. Tear and ocular surface profile in adult anopthalmic sockets. Philipp J Ophthalmol. 2012;37:104–10.
Rokohl AC, Trester M, Mor JM, Loreck N, Koch KR, Heindl LM. Customizing a Cryolite Glass Prosthetic Eye. J Vis Exp. 2019;18:453–9.
Rokohl AC, Trester M, Guo Y, Adler W, Jaeger VK, Loreck N et al. Dry anophthalmic socket syndrome – standardized clinical evaluation of symptoms and signs. The Ocular Surf. 2020;18:453–9.
Jacobi C, Bellios N, Jacobi A, Kruse F, Cursiefen C. Screening questionnaire for documentation of medical history and diagnostic findings in dry eye disease. Klin Monbl Augenheilkd. 2011;228:226–33.
Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33:55–60.
Simpson TL, Situ P, Jones LW, Fonn D. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci. 2008;85:692–9.
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–21.
Amparo F, Schaumberg DA, Dana R. Comparison of two questionnaires for dry eye symptom assessment: the Ocular Surface Disease Index and the symptom assessment in dry eye. Ophthalmology. 2015;122:1498–503.
Villani E, Beretta S, De Capitani M, Galimberti D, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in Sjogren’s syndrome. Invest Ophthalmol Vis Sci. 2011;52:933–9.
Villani E, Baudouin C, Efron N, Hamrah P, Kojima T, Patel SV, et al. In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res. 2014;39:213–31.
Wang J, Palakuru JR, Aquavella JV. Correlations among upper and lower tear menisci, noninvasive tear break-up time, and the Schirmer test. Am J Ophthalmol. 2008;145:795–800.
Acknowledgements
The authors thank Heidelberg Engineering GmbH, Dossenheim, Germany for providing the Heidelberg Retina Tomograph III and the Rostock Cornea Module free of charge. Open Access funding enabled and organized by Projekt DEAL.
Funding
GEROK program of the University of Cologne to ACR; supported by the Cologne Clinician Scientist Program (CCSP), Faculty of Medicine, University of Cologne, funded by the German Research Foundation (DFG, FI 773/15-1) to ACR; German Research Foundation (FOR2240 “[Lymph]Angiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye”); HE 6743/3–1, HE 6743/3-2, and HE 6743/5–1 to LMH; the Heidelberg Retina Tomograph III and the Rostock Cornea Module were provided free-of-charge by Heidelberg Engineering GmbH, Dossenheim, Germany. The company did not influence data management nor interpretation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
FB is an employee of Novartis Pharma GmbH Germany since October 2019. MT is the owner of the Trester Institute for Ocular Prosthetics and Artificial Eyes. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in the manuscript. All authors have full control of all primary data and they agree to allow Eye to review their data upon request.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of the University of Auckland and of the University of Cologne and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rokohl, A.C., Trester, M., Naderi, P. et al. Dry anophthalmic socket syndrome – morphological alterations in meibomian glands. Eye 35, 3358–3366 (2021). https://doi.org/10.1038/s41433-021-01426-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-021-01426-z
This article is cited by
-
Eviszeration, Enukleation, Exenteration – Indikationen, Techniken und postoperative Nachsorge
Die Ophthalmologie (2023)
-
How to diagnose dry anophthalmic socket syndrome (DASS) in the clinical routine
Graefe's Archive for Clinical and Experimental Ophthalmology (2023)
-
Aktuelle Aspekte der augenprothetischen Versorgung
Die Ophthalmologie (2023)
-
Novel point-of-care biomarkers of the dry anophthalmic socket syndrome: tear film osmolarity and matrix metalloproteinase 9 immunoassay
Graefe's Archive for Clinical and Experimental Ophthalmology (2023)
-
Komplikationen der anophthalmischen Orbita – Therapie und Nachsorge
Die Ophthalmologie (2023)